CrossGen Wealth LLC Takes Position in CME Group Inc. $CME

CrossGen Wealth LLC bought a new stake in shares of CME Group Inc. (NASDAQ:CME) in the 4th quarter, Holdings Channel.com reports. The firm bought 6,788 shares of the financial services provider’s stock, valued at approximately $1,854,000. CME Group makes up approximately 1.6% of CrossGen Wealth LLC’s holdings, making the stock its 21st largest position.

Other hedge funds also recently made changes to their positions in the company. SG Americas Securities LLC lifted its stake in CME Group by 345.2% during the fourth quarter. SG Americas Securities LLC now owns 237,898 shares of the financial services provider’s stock worth $64,965,000 after purchasing an additional 184,459 shares during the period. Dover Advisors LLC grew its stake in shares of CME Group by 95.5% in the 3rd quarter. Dover Advisors LLC now owns 5,597 shares of the financial services provider’s stock valued at $1,512,000 after purchasing an additional 2,734 shares during the period. FLC Capital Advisors bought a new stake in shares of CME Group in the 4th quarter valued at approximately $2,122,000. Lansforsakringar Fondforvaltning AB publ raised its holdings in shares of CME Group by 1.6% in the 3rd quarter. Lansforsakringar Fondforvaltning AB publ now owns 114,411 shares of the financial services provider’s stock worth $30,913,000 after buying an additional 1,777 shares in the last quarter. Finally, First Bank & Trust acquired a new position in shares of CME Group in the 4th quarter worth approximately $1,325,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently commented on CME shares. Weiss Ratings lowered CME Group from a “buy (a-)” rating to a “buy (b+)” rating in a research note on Thursday, June 11th. Jefferies Financial Group dropped their price objective on CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a research note on Thursday, April 9th. Morgan Stanley cut their price objective on CME Group from $362.00 to $353.00 and set an “overweight” rating for the company in a report on Thursday, April 23rd. Rothschild & Co Redburn upgraded shares of CME Group from a “neutral” rating to a “buy” rating and boosted their target price for the company from $316.00 to $323.00 in a research note on Thursday, June 11th. Finally, TD Cowen lowered their target price on shares of CME Group from $340.00 to $323.00 and set a “buy” rating on the stock in a report on Thursday, April 23rd. Twelve investment analysts have rated the stock with a Buy rating, four have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $305.18.

CME Group Stock Down 2.4%

NASDAQ CME opened at $246.38 on Friday. The firm has a market cap of $89.28 billion, a PE ratio of 21.02, a price-to-earnings-growth ratio of 2.82 and a beta of 0.21. CME Group Inc. has a one year low of $244.56 and a one year high of $329.16. The stock’s 50 day simple moving average is $280.74 and its 200 day simple moving average is $287.50. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.11 by $0.25. The firm had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business’s revenue for the quarter was up 14.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.80 EPS. As a group, sell-side analysts forecast that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be given a dividend of $1.30 per share. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 annualized dividend and a yield of 2.1%. CME Group’s dividend payout ratio is 44.37%.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Neutral Sentiment: CME announced a planned CEO succession: longtime chief Terry Duffy will step down in March 2027 and transition to executive chairman, while President and CFO Lynne Fitzpatrick will become CEO. The move also makes Fitzpatrick CME’s first woman chief executive, which supports continuity but adds some near-term uncertainty around the handoff. Article Title
• Neutral Sentiment: The company also highlighted its long-term leadership change in multiple interviews and reports, which may reassure investors that the transition is orderly rather than sudden. Article Title
• Negative Sentiment: CME said it plans to sue the CFTC over approval of crypto perpetual futures, arguing the regulator is improperly treating these products as swaps rather than futures. The legal fight raises regulatory risk and could create uncertainty around CME’s crypto derivatives strategy. Article Title
• Negative Sentiment: Several headlines repeated the lawsuit plan, suggesting the issue is the main driver of today’s weakness as investors focus on possible friction with regulators and the implications for future product approvals. Article Title

Insider Transactions at CME Group

In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the sale, the insider owned 27,702 shares of the company’s stock, valued at $8,438,860.26. This represents a 17.20% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the sale, the chief executive officer owned 55,630 shares of the company’s stock, valued at $16,606,111.30. The trade was a 38.62% decrease in their position. The SEC filing for this sale provides additional information. 0.30% of the stock is owned by corporate insiders.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.